(Press-News.org)
Automated insulin delivery (AID) systems such as the UVA Health-developed artificial pancreas could help more type 1 diabetes patients if the devices become fully automated, according to a new review of the technology.
Even as the artificial pancreas and other AID systems have helped millions of people with type 1 diabetes better manage their blood sugar and improve their overall health, there are still limitations to overcome, according to the review from University of Virginia Center for Diabetes Technology scientists and their colleagues. These limitations include:
AID systems are not yet fully automated; users must input their meals and exercise to avoid dangerous spikes or drops in blood-sugar levels.
The systems work best overnight, when there are no meals or exercise.
AID systems are not yet usable by all patients with type 1 diabetes, including women who are pregnant and older adults.
“These automated insulin delivery devices have significantly helped people with type 1 diabetes manage their blood sugars and yet challenges still remain – people still need to remember to give insulin for meals as well as carbohydrate counts,” said Sue A. Brown, MD, an endocrinologist and researcher at the UVA Center for Diabetes Technology who co-authored the paper, “These newer approaches can help alleviate those requirements and we are hopeful that we can make insulin management even easier for people with type 1 diabetes.”
Treatment Advances on the Horizon
A key goal, the researchers write, is to fully automate AID systems – also known as full closed-loop systems – so the devices require less or no interaction. In pursuit of this, UVA Center for Diabetes researchers are conducting home-based clinical trials testing a system that merges artificial intelligence and advanced model-based algorithms to deliver insulin around meals independently of any user-machine interactions.
Researchers at other institutions are developing artificial intelligence approaches that automatically detect meals and deliver corresponding insulin doses. Researchers are also testing full closed-loop systems that deliver both insulin and glucagon, which is used to treat low blood sugar.
“While AID has revolutionized diabetes care, most patients using insulin do not yet have access to such technology. Simplifying the use of these systems will greatly improve access,” said Marc Breton, PhD, associate professor of research at the UVA Center for Diabetes Technology and co-author of the paper. “UVA is at the forefront of another revolution: the use of artificial intelligence and data science at the very core of medical devices. Over the next couple of years, we will deploy adaptive, personalized and fully automated AID systems based on artificial neural networks and further enable safe, private, and efficacious management of this ever-growing condition.”
Celebrating Advances in Diabetes Care
The paper is part of a collection of research articles on automated insulin delivery and UVA’s artificial pancreas co-edited by Boris Kovatchev, PhD, director of the Center for Diabetes Technology, to commemorate the 75th anniversary of the National Institute of Health’s National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK).
“The translation of artificial pancreas technology was one of the most important NIDDK achievements in the past 20 years. The institute’s support was critical for this development, which now benefits hundreds of thousands of people with type 1 diabetes,” Kovatchev said. ‘The UVA Center for Diabetes Technology played a central role in this progress as evidenced by the acknowledgement of the center in the 2021-2025 NIDDK Strategic Plan. It is therefore logical that several UVA faculty were invited authors of the NIDDK’s 75th anniversary collection, including Marc Breton, Sue Brown, Chiara Fabris, Linda Gonder-Frederick, Mark DeBoer and Daniel Cherñavvsky.”
Findings Published
Breton, Brown and their collaborators have simultaneously published their paper in the journals Diabetes Technology & Therapeutics and the Journal of Diabetes Science and Technology. The research team consisted of Peter G. Jacobs, Carol J. Levy, Brown, Michael C. Riddell, Ali Cinar, Charlotte K. Boughton, Breton, Eyal Dassau, Greg Forlenza, Robert J. Henderson, Roman Hovorka, David M. Maahs, Medha Munshi, Helen Murphy, Sarit Polsky, Richard Pratley, Melissa S. Putman, Viral N. Shah, Leah M. Wilson, Howard Zisser and Laya Ekhlaspour.
To keep up with the latest medical research news from UVA, subscribe to the Making of Medicine blog.
END
West Nile virus (WNV) has been the dominant cause of mosquito-borne illness in the United States since its introduction into North America in 1999. There are no vaccines nor medications to prevent or treat illness in people, so surveillance, prevention, and control remain the best options to protect the public. Mosquito surveillance for WNV is a central component of the public health response, but this approach is labor intensive and limited by practical constraints on the number of locations that can be sampled. To address this limitation, Joseph McMillan and colleagues developed a validated machine learning model that uses freely ...
Sub-Saharan Africa currently has the highest infant mortality rate in the world, with 27 babies out of every 1,000 live births dying in their first month. As the climate warms, pregnant women in the region are increasingly exposed to extreme heat, which can cause reduced placental blood flow and dehydration, potentially affecting fetal development. In addition, extreme heat can lead to the proliferation of pathogenic bacteria in the environment, and can make it difficult for women to travel to prenatal care appointments. Jiafu An and colleagues sought to determine whether in-utero exposure to extreme ...
MINNEAPOLIS / ST. PAUL (08/19/2025) — Researchers at the University of Minnesota Twin Cities have made a groundbreaking discovery by observing and analyzing the first new type of plasma wave in Jupiter’s aurora. This research helps us understand “alien aurora” on other planets, which in turn teaches us more about how Earth’s magnetic field protects us from the sun’s harmful radiation.
The research is published in Physical Review Letters, a peer-reviewed, multidisciplinary, high-impact scientific journal.
The observation is based on data from NASA’s Juno spacecraft, which made a historic low ...
Stroke remains one of the leading causes of long-term disability worldwide, affecting millions each year. Among its most debilitating consequences is gait impairment, which affects over 80% of stroke survivors. Impaired walking not only reduces independence but also limits participation in daily and social activities, significantly diminishing the quality of life. While some patients regain partial ambulatory function, walking speed and coordination often remain impaired. Alarmingly, up to 22% of survivors never regain the ability to walk and are ...
Cerebrovascular diseases such as atherosclerosis and stroke remain a major cause of morbidity and mortality worldwide. A common feature of these diseases is vascular stenosis, i.e., the narrowing of blood vessels, which disrupts normal blood flow and contributes to chronic inflammation in the vessel wall. Endothelial cells lining the vasculature play a key role in sensing shear stress from blood flow and responding to disturbed hemodynamics by expressing pro-inflammatory molecules. However, studying this phenomenon in vivo is challenging due to the complexity ...
The tongue contains numerous taste buds—tiny sensory organs responsible for detecting taste. Taste buds consist of specialized cells that translate chemical stimuli into neural signals. Among them, type II cells, which respond to sweet, umami, and bitter stimuli, utilize channel-based signal transmission. In contrast, type III cells are believed to mediate sour signals via synaptic vesicle release. While the signaling mechanisms of type II cells are well-characterized, the process of vesicular synaptic transmission in type III cells is poorly understood.
Synaptic signal transmission relies on the SNARE complex, ...
The International Progressive MS Alliance announces the launch of its MS Clinical and Imaging Data Resource (CIDR), which provides the academic and research community access to anonymized and harmonized MRI and clinical data from thousands of people living with MS who participated in one of many clinical trials. The Alliance, in conjunction with McGill University in Montréal, Canada, and four industry partners – Biogen, Novartis, Roche and Sanofi - is making this resource available exclusively to the MS research community to help accelerate ...
Osaka, Japan－Researchers at The University of Osaka have discovered a new type of chiral symmetry breaking (CSB) in an organic crystalline compound. This phenomenon, involving a solid-state structural transition from an achiral to a chiral crystal, represents a significant advance in our understanding of chirality and offers a simplified model to study the origin of homochirality. This transformation also activates circularly polarized luminescence, enabling new optical materials with tunable light properties.
Chirality, or "handedness," is a fundamental property of objects, from galaxies to molecules, and plays a crucial role in biological ...
A newly developed system transforms human waste into a powerful tool for profitable and sustainable energy and agriculture in resource-limited regions. The prototype, outlined in a Stanford-led study published Aug 19 in Nature Water, recovers a valuable fertilizer from urine, using solar energy that can also provide power for other uses. In the process, the system provides essential sanitation, making wastewater safer to discharge or reuse for irrigation.
“This project is about turning a waste problem into a resource opportunity,” said study ...
Aging is particularly harsh on the hippocampus — the brain region responsible for learning and memory.
Now, researchers at UC San Francisco have identified a protein that’s at the center of this decline.
They looked at how the genes and proteins in the hippocampus changed over time in mice and found just one that differed between old and young animals. It’s called FTL1.
Old mice had more FTL1, as well as fewer connections between brain cells in the hippocampus and diminished cognitive abilities.
When the researchers artificially increased FTL1 levels in young mice, their ...
